all report title image
  • Published On : Jan 2023
  • Code : CMI5456
  • Industry : Medical Devices
  • Pages : 217
  • Formats :

Percutaneous discectomy is an option for vertebrae that cannot be fixed surgically, such as those affected by osteoporosis or in which general anesthesia may not be recommended in critically ill patients. Utilizing kyphoplasty, a particular cement is injected into the vertebrae, and an additional step is taken to make room for the procedure with a balloon-like device (balloon vertebroplasty). Kyphoplasty can increase the height of a damaged vertebra and may also be pain-relieving.

Global kyphoplasty and percutaneous discectomy procedure market is estimated to be valued at US$ 2,079.4 million in 2022 and is expected to exhibit a CAGR of 5.7% during the forecast period (2022-2030).

Figure 1.Global Kyphoplasty and Percutaneous Discectomy Procedure Market Share (%), by Procedure, 2022

Kyphoplasty and Percutaneous Discsectomy Procedure  | Coherent Market Insights

Global Kyphoplasty and Percutaneous Discectomy Procedure Market- Drivers

Increasing prevalence of Vertebral Compression Fractures (VCF), osteoporosis, and other spinal disorders is expected to drive market growth over the forecast period. For instance, according to the American Association of Neurological Surgeons, VCFs are the most common fracture in patients with osteoporosis, that affect about 750,000 people annually in the U.S. VCFs affect an estimated 25% of all postmenopausal women in the U.S.

The increasing demand for minimally invasive surgical procedures in orthopedics and thereby improvements in reimbursement policies is expected to further drive the market growth. For instance, in September 2020, the SpineJack implantable fracture reduction system of Stryker, a multinational medical technologies company, received the U.S. Centers for Medicare & Medicaid Services (CMS) New Technology Add-on Payment (NTAP) as part of the 2021 inpatient prospective payment system. The SpineJack System is an implanted fracture reduction system, intended to reduce vertebral compression fractures. After the SpineJack implant is inserted, it is expanded, and Vertaplex HV bone cement is injected at a low pressure to stabilize the restored vertebral body.

CMI table icon

Kyphoplasty and Percutaneous Discsectomy Procedure Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 2,079.4 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 5.7% 2030 Value Projection: US$ 3,230.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Procedure: Kyphoplasty, Percutaneous Discectomy
  • By Application: Vertebral Alignment Restoration, Spinal Fractures, Kyphosis, Others
  • By End User: Hospitals, Clinics, Ambulatory Surgical Center, Others
Companies covered:

Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company , Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, Seawon MediTech

Growth Drivers:
  • Increasing prevalence of vertebral compression fractures (VCF), osteoporosis, and other spinal disorders
  • Improving reimbursement policies
Restraints & Challenges:
  • High cost of spinal surgeries

Figure 2. Global Kyphoplasty and Percutaneous Discectomy Procedure Market Share (%), by Application, 2022

Kyphoplasty and Percutaneous Discsectomy Procedure  | Coherent Market Insights

Global Kyphoplasty and Percutaneous Discectomy Procedure Market– Impact of Coronavirus (COVID-19) Pandemic

Lockdown or shut down due to covid 19 was imposed in many countries globally, which had a negative impact on the economy of the private healthcare sector globally. This lockdown resulted in the closure of industrial establishments, except for the manufacturing of essential commodities, and disruption in the supply chain of products. Thus, the COVID-19 pandemic has affected the economy in three main ways: by directly affecting the production and demand o by creating disruptions in distribution channels o through its financial impact on firms and financial markets.  The COVID-19 outbreak is anticipated to have a negative impact on the global kyphoplasty and percutaneous discectomy procedure market. Several clinics and hospitals all around the world undertook restructuring to increase hospital capacity for patients with COVID-19 diagnoses. The high rise in COVID-19 cases resulted in a potential backlog in non-essential procedures.  For instance, as per a study published in May 2020, in Asian Spine Journal, spine surgical procedures decreased by approximately 50% in the first month of covid wave in France as compared to the same period in 2019.

Global Kyphoplasty and Percutaneous Discectomy Procedure Market: Key Developments

In September 2021, Spinal Elements, a spine technology company, announced the full commercial launch of the Luna XD multiexpandable lumbar interbody fusion device and Orbit articulating discectomy systems. Luna XD and Orbit have been integrated into Spinal Elements as the newest technologies in its Minimally Invasive Spine (MIS) Ultra platform of products and procedural solutions.

In January, Merit Medical Systems, a manufacturer and marketer of proprietary disposable medical devices, announced the official market launch of Arcadia Steerable and Straight Balloons for vertebral augmentation. Arcadia balloons are designed to help physicians achieve controlled, precise cavity creation during unipedicular or bipedicular vertebral augmentation and kyphoplasty procedures

Global Kyphoplasty and Percutaneous Discectomy Procedure Market: Restraint

The high cost of minimally invasive procedures is expected to hamper the market growth. The price of spinal surgeries is very high, which can hamper the market growth.  For instance, according to New Choice Health, Inc., a free, consumer-focused healthcare marketplace, the national average cost of vertebral augmentation surgery such as vertebroplasty and kyphoplasty is US$ 36,880 in the U.S. According to the same source, the average price range for kyphoplasty is US$ 11,300 to US$ 31,000 in the U.S.

Global Kyphoplasty and Percutaneous Discectomy Procedure  Market- Key Players

Major players operating in the global kyphoplasty and percutaneous discectomy procedure market include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech

Kyphoplasty is carried out by a small skin puncture rather than a bigger (open) incision, it is regarded as a minimally invasive procedure. Kyphoplasty/vertebroplasty is a method of treating vertebral body compression fractures, which are small breaks in the dense mass of bone that makes up the front part of the spinal column. The treatment typically takes one to two hours per vertebral level, as explained below (the vertebral body). The spine shortens and curves forward as a result of vertebral body fractures that cause a vertebra to collapse or get compressed. Pain and a kyphotic (hunched-over) deformity may occur from this. Vertebral compression fractures are most commonly caused by osteoporosis, which causes thinning of the bones. Another potential factor is pathologic fractures linked to spine tumors. A percutaneous discectomy is a procedure that removes part of a herniated disc that is irritating a nerve, resulting in prompt pain relief. The spinal column is made up of bony vertebrae. Between each vertebra, there are soft rubbery structures called discs. When a disc is herniated, the inside of the disc starts to protrude into the spinal canal and put pressure on the nerves, causing pain in the back, legs, neck, or arms.

Market Dynamics

Increasing adoption of inorganic strategies by key players in the market such as acquisitions is expected to drive market growth over the forecast period. For instance, in December 2020, Spinal Elements, a spine technology company, announced the acquisition of the assets of Benvenue Medical, Inc., a developer of minimally invasive surgical (MIS) lumbar fusion systems. Among the assets were the Luna XD multi-expandable lumbar fusion device and the Orbit Articulating Discectomy System.

Key features of the study:

  • This report provides in-depth analysis of the global kyphoplasty and percutaneous discectomy procedure market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global  kyphoplasty and percutaneous discectomy procedure   market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global  kyphoplasty and percutaneous discectomy procedure   market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global  kyphoplasty and percutaneous discectomy procedure   market

Detailed Segmentation:

  • Global Kyphoplasty And Percutaneous Discectomy Procedure Market, By Procedure :
    • Kyphoplasty
    • Percutaneous Discectomy
  • Global Kyphoplasty And Percutaneous Discectomy Procedure Market, By Application:
    • Vertebral Alignment Restoration
    • Spinal Fractures
    • Kyphosis
    • Others
  • Global Kyphoplasty And Percutaneous Discectomy Procedure Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Center
    • Others
  • Global Kyphoplasty And Percutaneous Discectomy Procedure Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Stryker
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Stryker
    • Medtronic Inc.
    • BPB Medica – Biopsybell
    • Smith & Nephew
    • MicroPort Scientific Corporation
    • Johnson & Johnson
    • Halma plc
    • Becton, Dickinson and Company
    • Merit Medical Systems
    • Joimax GmbH
    • G21 S.r.l.
    • Joline GmbH & Co. KG
    • Seawon MediTech

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global kyphoplasty and percutaneous discectomy procedure market is estimated to be valued at US$ 2,079.4 million in 2022 and is expected to exhibit a CAGR of 5.7% between 2022 and 2030.
Factors such as the increasing prevalence of Vertebral Compression Fractures (VCF), osteoporosis, and other spinal disorders and improving reimbursement policies are expected to drive the market.
Spinal Fractures is the leading application segment in the market.
The major factors hampering the growth of the global kyphoplasty and percutaneous discectomy procedure market include the high cost of spinal surgeries and the presence of alternative surgeries.
Major players operating in the market include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo